Actively Recruiting
Collection of Blood for Multiple Collaborative Studies
Led by University of California, San Francisco · Updated on 2026-04-13
2000
Participants Needed
1
Research Sites
2191 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study seeks to confidentially collect blood from HIV-positive individuals and HIV-negative controls to provide basic scientists with specimens for collaborative studies.
CONDITIONS
Official Title
Collection of Blood for Multiple Collaborative Studies
Who Can Participate
Eligibility Criteria
You may qualify if you...
- HIV-1 antibody negative with similar characteristics to HIV-1 positive cohort
- HIV-positive subjects naive to antiretroviral therapy
- HIV-positive subjects stable on or off antiretroviral therapy for a minimum of 6 months
- Good venous access
- Able to provide informed consent
You will not qualify if you...
- Hemoglobin < 9g/dl
- Hematocrit < 27%
- Active treatment for cancer
- Hospitalization or IV antibiotic use within the last 4 months
- Immunosuppressive therapy within the last 4 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
San Francisco General Hospital
San Francisco, California, United States, 94110
Actively Recruiting
Research Team
R
Rebecca Hoh, M.S., R.D.
CONTACT
V
Viva Tai, MS. RD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here